SV Health Investors (investor - Private Equity)

See something wrong or missing? Let us know
Offices:London
Average round investment:50.81M USD
Average number per year:2.7
Distribution: 2025 (3)2024 (2)2023 (3)2022 (3)2021 (4) See the entire list
Mostly invests in: United Kingdom United Kingdom (14) Health services (16)
See the entire list

Showing 3 of 16 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

SV Health Investors mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to SV Health Investors

Name Criteria
Belgium V-Bio Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
United States Pfizer Venture Investments
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Ireland
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Germany DTCP
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Hardware, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
United Kingdom Syncona
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Switzerland Pictet Group
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Hardware, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
Sweden HealthCap
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Ireland
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
France Sanofi Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Hardware, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Germany Yabeo
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Australia Brandon Capital Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
United States Adjuvant Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Top